Sigma-Aldrich’s closely inter-related units have earned a reputation for quality and performance

Sigma-Aldrich Corporation’s chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. It has customers in life science companies, university and government institutions, hospitals and in the industry.

In the life science area, it provides  a range of products for molecular biology, protein expression and proteomics, cell biology, functional genomics and transgenics.  Sigma-Aldrich witnessed a 23 percent growth in India in life sciences space. According to BioSpectrum the life sciences revenue of Sigma-Aldrich is estimated at 123 crore in 2010-11 against previous year’s estimated life sciences revenue of 100 crore.

Sigma Life Science, a Sigma-Aldrich  brand, had the global release of a pioneering range of engineered mammalian cell lines in September 2010.

This new product range combines Sigma’s proprietary CompoZr zinc finger nuclease (ZFN) technology with its extensive experience in gene silencing, to offer innovative tools for drug discovery, compound screening and fundamental research applications.

During early 2011, Sigma added new modified cancer cells to it’s range of high-quality cell lines. These human knockout and knock-in oncology cell lines, created using Sigma’s proprietary ZFN technology, offer researchers cellular models of cancer that are expected to enhance development of drugs for personalized medicine.
The company has four business units Essentials, Specialties Research and Biotech Research and the Fine Chemicals Unit, SAFC.

Globally, the company operates in 40 countries, manufacturing 48,000 of the 130,000 chemical products it offers. The company also offers 40,000 equipment products and sells it in over 160 countries, servicing over 92,000 accounts, which represents over one million individual customers.